ReNeuron Group (RENE) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Dec 2010 07:00 AM
RNS
Update on clinical trial
20 Dec 2010 08:01 AM
RNS
SECOND ADMISSION
17 Dec 2010 08:01 AM
RNS
FIRST ADMISSION
13 Dec 2010 07:01 AM
RNS
Interim Results
13 Dec 2010 07:00 AM
RNS
£10 million Fundraising
01 Dec 2010 07:00 AM
RNS
Block Listing Six Monthly Rev
17 Nov 2010 04:41 PM
RNS
Second Price Monitoring Extn
17 Nov 2010 04:35 PM
RNS
Price Monitoring Extension
17 Nov 2010 07:00 AM
RNS
Progress update on ReN009
16 Nov 2010 07:00 AM
RNS
First Patient Treated with Re
27 Oct 2010 07:00 AM
RNS
ReNeuron at stem cell and neu
08 Oct 2010 10:26 AM
RNS
18th Annual BioPartnering Eur
21 Sep 2010 07:00 AM
RNS
ReNeuron to present at key UK
08 Sep 2010 11:07 AM
RNS
Results of 2010 Annual Genera
08 Sep 2010 07:00 AM
RNS
2010 AGM Trading Update
09 Aug 2010 07:00 AM
RNS
Posting of Report and Account
03 Aug 2010 07:00 AM
RNS
Director/PDMR Shareholding
15 Jul 2010 07:00 AM
RNS
Notification of Investor Even
12 Jul 2010 07:00 AM
RNS
Result of pre-clinical studie
29 Jun 2010 07:00 AM
RNS
Preliminary Results
17 Jun 2010 07:00 AM
RNS
Preliminary Results Notificat
13 May 2010 02:38 PM
RNS
Block listing application
29 Apr 2010 07:00 AM
RNS
New positive data to be prese
01 Apr 2010 09:58 AM
RNS
Holding in Company
31 Mar 2010 04:35 PM
RNS
Holding(s) in Company
22 Mar 2010 10:44 AM
RNS
ReNeuron cited as UK regenera
18 Mar 2010 07:00 AM
RNS
ReNeuron signs further manufa
15 Mar 2010 02:44 PM
RNS
Second Closing of the Placing
12 Mar 2010 12:18 PM
RNS
Result of General Meeting
03 Mar 2010 07:00 AM
RNS
ReNeuron presents pre-clinica
22 Feb 2010 07:00 AM
RNS
ReNeuron Announces Fundraisin
18 Feb 2010 07:00 AM
RNS
Retinal Stem Cell Research Gr
10 Feb 2010 07:00 AM
RNS
Final Approval Received To Co
08 Feb 2010 12:55 PM
RNS
Issue of Ordinary Shares
01 Feb 2010 07:00 AM
RNS
Clinical Advisory Board appoi
28 Jan 2010 07:00 AM
RNS
Regulatory update
27 Jan 2010 11:42 AM
RNS
ReNeuron welcomes "Life Scien
11 Jan 2010 07:00 AM
RNS
Regulatory update
01 Dec 2009 07:00 AM
RNS
Issue of Ordinary Shares
27 Nov 2009 07:00 AM
RNS
Two grants awarded by regener
26 Nov 2009 07:02 AM
RNS
£5 million equity funding fac
26 Nov 2009 07:00 AM
RNS
Half Yearly Report
23 Nov 2009 07:00 AM
RNS
Notice of Results
16 Nov 2009 07:00 AM
RNS
Positive data presented at le
22 Oct 2009 01:49 PM
RNS
ReNeuron to present at Royal
02 Oct 2009 07:00 AM
RNS
Publication of new research u
17 Sep 2009 10:47 AM
RNS
Result of AGM
17 Sep 2009 07:00 AM
RNS
AGM Statement
14 Sep 2009 07:02 AM
RNS
Trading Platform
14 Sep 2009 07:00 AM
RNS
Change of Adviser

ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several exosome producer cell lines, its CustomEX platform can be optimized for specific tissue targets and payloads, leading to improvements in therapeutic outcome and a reduction in off-target effects. It offers a delivery mechanism for a variety of payloads such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. Through its conditionally immortalized induced pluripotent stem cell (iPSC) platform, it has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.

It listed on AIM in 2006 under the ticker RENE.

UK 100